{"body":"<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>adherence<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Compliance with a regimen (chemoprophylaxis or treatment) or with procedures and practices prescribed by a health care worker<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>adverse drug reaction<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A response to a medicine that is harmful and unintended and which occurs at doses normally used in humans<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>adverse event<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Any untoward medical occurrence in a person exposed to a biological or chemical product, which does not necessarily have a causal relationship with the product<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>adverse event, serious<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Any untoward medical occurrence in a person exposed to a biological or chemical product, which is not necessarily causally related to the product, and results in death, requirement for or prolongation of inpatient hospitalization, significant disability or incapacity or is life-threatening<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>aestivation<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A process by which mosquitoes at one or several stages (eggs, larvae, pupae, adults) survive by means of behavioural and physiological changes during periods of drought or high temperature<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>age group<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Subgroup of a population classified by age. The following grouping is usually recommended:<\/p>&#13;\n&#13;\n<ul><li>0\u201311 months<\/li>&#13;\n\t<li>12\u201323 months<\/li>&#13;\n\t<li>2\u20134 years<\/li>&#13;\n\t<li>5\u20139 years<\/li>&#13;\n\t<li>10\u201314 years<\/li>&#13;\n\t<li>15\u201319 years<\/li>&#13;\n\t<li>\u2265 20 years<\/li>&#13;\n<\/ul><\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>age, physiological<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Adult female mosquito age in terms of the number of gonotrophic cycles completed: nulliparous, primiparous, 2-parous, 3-parous et seq.<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>age-grading, of female adult mosquitoes<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Classification of female mosquitoes according to their physiological age (number of gonotrophic cycles) or simply as nulliparous or parous (parity rate)<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>age-grading, of mosquito larvae<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Classification of mosquito larvae as instars (development stages) 1, 2, 3 and 4<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>annual blood examination rate<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The number of people receiving a parasitological test for malaria per unit population per year<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong><em>Anopheles<\/em>, infected<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Female <em>Anopheles <\/em>mosquitoes with detectable malaria parasites<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong><em>Anopheles<\/em>, infective<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Female <em>Anopheles<\/em> mosquitoes with sporozoites in the salivary glands<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>anopheline density<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Number of female anopheline mosquitoes in relation to the number of specified shelters or hosts (e.g. per room, per trap or per person) or to a given period (e.g. overnight or per hour), specifying the method of collection<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>anthropophilic<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Description of mosquitoes that show a preference for feeding on humans, even when non-human hosts are available<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>antimalarial medicine<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A pharmaceutical product used in humans for the prevention, treatment or reduction of transmission of malaria<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>artemisinin-based combination therapy<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A combination of an artemisinin derivative with a longer-acting antimalarial drug that has a different mode of action<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>basic reproduction number<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The number of secondary cases that a single infection (index case) would generate in a completely susceptible population (referred to as R0)<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>bioassay<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">In applied entomology, experimental testing of the biological effectiveness of a treatment (e.g. infection, insecticide, pathogen, predator, repellent) by deliberately exposing insects to it<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>biological insecticide*<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Pesticides made from natural materials that are meant to kill or control insects. These natural source materials may include animals, plants, bacteria or minerals<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>biting rate<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Average number of mosquito bites received by a host in a unit time, specified according to host and mosquito species (usually measured by human landing collection)<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>capture site<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Site selected for periodic sampling of the mosquito population of a locality for various purposes<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, confirmed<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Malaria case (or infection) in which the parasite has been detected in a diagnostic test, i.e. microscopy, a rapid diagnostic test or a molecular diagnostic test<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, fever<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The occurrence of fever (current or recent) in a person<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, imported<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Malaria case or infection in which the infection was acquired outside the area in which it is diagnosed<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, index<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A case of which the epidemiological characteristics trigger additional active case or infection detection. The term \u201cindex case\u201d is also used to designate the case identified as the origin of infection of one or a number of introduced cases<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, indigenous<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A case contracted locally with no evidence of importation and no direct link to transmission from an imported case<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, induced<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A case the origin of which can be traced to a blood transfusion or other form of parenteral inoculation of the parasite but not to transmission by a natural mosquito-borne inoculation<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, introduced<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A case contracted locally, with strong epidemiological evidence linking it directly to a known imported case (first-generation local transmission)<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, locally acquired<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A case acquired locally by mosquito-borne transmission<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, malaria<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Occurrence of malaria infection in a person in whom the presence of malaria parasites in the blood has been confirmed by a diagnostic test<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, presumed<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Case suspected of being malaria that is not confirmed by a diagnostic test<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, recrudescent<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Malaria case attributed to the recurrence of asexual parasitaemia after antimalarial treatment, due to incomplete clearance of asexual parasitaemia of the same genotype(s) that caused the original illness. A recrudescent case must be distinguished from reinfection and relapse, in the case of <em>P. vivax<\/em> and <em>P. ovale<\/em><\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, relapsing<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Malaria case attributed to activation of hypnozoites of <em>P. vivax<\/em> or <em>P. ovale<\/em> acquired previously<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case, suspected malaria<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Illness suspected by a health worker to be due to malaria, generally on the basis of the presence of fever with or without other symptoms<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case detection<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">One of the activities of surveillance operations, involving a search for malaria cases in a community<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case detection, active<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Detection by health workers of malaria cases at community and household levels, sometimes in population groups that are considered at high risk. Active case detection can consist of screening for fever followed by parasitological examination of all febrile patients or as parasitological examination of the target population without prior screening for fever<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case detection, passive<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Detection of malaria cases among patients who, on their own initiative, visit health services for diagnosis and treatment, usually for a febrile illness<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case follow-up<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Periodic re-examination of patients with malaria (with or without treatment)<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case investigation<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Collection of information to allow classification of a malaria case by origin of infection, i.e. imported, indigenous, induced, introduced, relapsing or recrudescent<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case management<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Diagnosis, treatment, clinical care, counselling and follow-up of symptomatic malaria infections<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>case notification<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Compulsory reporting of all malaria cases by medical units and medical practitioners to either the health department or the malaria control programme, as prescribed by national laws or regulations<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>catchment area<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A geographical area defined and served by a health programme or institution, such as a hospital or community health centre, which is delineated on the basis of population distribution, natural boundaries and accessibility by transport<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>cerebral malaria<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Severe <i>P. falciparum\u00a0<\/i>of malaria by detection of malaria parasites or\u00a0 malaria with impaired consciousness (Glasgow coma scale &lt; 11, Blantyre coma scale &lt; 3) persisting for &gt; 1 hour after a seizure<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>certification of malaria-free<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Certification granted by WHO after it has been proved beyond reasonable doubt that local human malaria transmission by Anopheles mosquitoes has been interrupted in an entire country for at least three consecutive years and a national surveillance system and a programme for the prevention of reintroduction are in place<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>chemoprevention, seasonal malaria<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Intermittent administration of full treatment courses of an antimalarial medicine during the malaria season to prevent malarial illness. The objective is to maintain therapeutic concentrations of an antimalarial drug in the blood throughout the period of greatest risk for malaria.<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>chemoprophylaxis<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Administration of a medicine, at predefined intervals, to prevent either the development of an infection or progression of an infection to manifest disease<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>cluster<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Aggregation of relatively uncommon events or diseases in space and\/or time in numbers that are considered greater than could be expected by chance<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>combination therapy<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A combination of two or more classes of antimalarial medicine with unrelated mechanisms of action<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>coverage<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A general term referring to the fraction of the population of a specific area that receives a particular intervention<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>coverage, optimal<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Optimal coverage is the outcome of an explicit prioritization process guiding resource allocation decisions. The process combines the analysis of impact and value for money with extensive stakeholder engagement and discussion that explicitly outlines the trade-offs involved in the selection of interventions and combining them in an intervention package. The process should take into account a country's programmatic goals, context-specific factors, and should consider equity implications of the resource allocation decisions.<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>coverage, universal health<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Ensuring all individuals and communities receive the health services they need without suffering financial hardship. It includes the full spectrum of essential quality health services from health promotion to prevention, treatment, rehabilitation, and palliative care.<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>cure<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Elimination from an infected person of all malaria parasites that caused the infection<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>cure, radical<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Elimination of both blood-stage and latent liver infection in cases of <em>P. vivax<\/em> and <em>P. ovale<\/em> infection, thereby preventing relapses<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>cure rate<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Percentage of treated individuals whose infection is cured<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>cyto-adherence<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Propensity of malaria-infected erythrocytes to adhere to the endothelium of the microvasculature of the internal organs of the host<\/p>&#13;\n<\/div>&#13;\n","title":"Glossary: A - C","nid":773,"vid":4338,"created":1627907317,"changed":1627907800,"field_content_type":{"tid":2,"name":"Content","class":"content"},"field_left_right_navigation":1,"field_operational_":[{"field_image":"","field_link":"","field_title":null}],"field_recommendations":1,"recommendation":"<p>All cases of suspected malaria should have a parasitological test (microscopy or Rapid diagnostic test (RDT)) to confirm the diagnosis.<br \/>\r\nBoth microscopy and RDTs should be supported by a quality assurance programme.<br \/>\r\n<font color=\"#4090CF\"><em>Good practice statement<\/em><\/font><\/p>\r\n","recommendation_title":"Rapid diagnostic test (RDT)","field_references":null}